neu/erbB-2 overexpression and response to hormonal therapy in premenopausal women in the adjuvant breast cancer setting: will it play in Peoria? part II

J Clin Oncol. 2003 Feb 1;21(3):399-400. doi: 10.1200/JCO.2003.11.038.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / surgery*
  • Chemotherapy, Adjuvant
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Genetic Markers*
  • Humans
  • Ovariectomy
  • Premenopause
  • Prognosis
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / biosynthesis*
  • Tamoxifen / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Genetic Markers
  • Tamoxifen
  • Receptor, ErbB-2